Association Between Serum Magnesium Levels and Glycemic Control in Type 2 Diabetes

Abstract

Introduction Serum magnesium is a crucial mineral within the human body. It is imperative for diabetic patients to maintain optimal serum magnesium levels. We focus on the relationship between glycemic control and serum magnesium in type 2 diabetes mellitus (T2DM). Methods The retrospective, observational, cross-sectional study comprised 1694 patients recruited from the People’s Hospital of Yuxi. Fasting blood samples were collected for analysis, accompanied by the recording of participants’ demographic characteristics. Patients were categorized into two groups based on whether their glycosylated hemoglobin (HbA1c) levels < 7%. A t -test was employed to identify significant differences between the two groups. Correlation coefficients were calculated using Pearson’s method. A Logistic regression analysis was conducted to assess the association between variables and glycemic control. A linear regression analysis was performed to assess the relationship between serum magnesium levels and HbA1c. Results Patients with poor glycemic control exhibited elevated age, low-density lipoprotein (LDL-C), fasting plasma glucose (FPG), and homeostasis model assessment (HOMA-IR) compared to those with good glycemic control (P < 0.001). Additionally, total cholesterol (TC) levels were significantly higher in patients with poor glycemic control. Conversely, high-density lipoprotein (HDL-C) and serum magnesium levels were lower in patients with poor glycemic control. Serum magnesium levels exhibited negative correlations with HOMA-IR (r = −0.05, P < 0.05), HbA1c (r = −0.29, P < 0.05), and FPG (r = −0.20, P < 0.05). Moreover, serum magnesium was significantly associated with reduced odds of glycemic control (OR = 0.0005, 95% CI 0.0001–0.0027, P < 0.001). Conclusion The serum magnesium level in patients with T2DM is closely associated with glycemic control.